1-2 of 2
Lucile Baseggio, PharmD, PhD
Close
Sort by
Journal Articles

Single-Agent Ibrutinib Vs Standard of Care for Patients with Relapsed/Refractory (R/R) and Treatment-Naive (TN) Chronic Lymphocytic Leukemia (CLL): An Adjusted Comparison of RESONATE TM and RESONATE-2 TM with the French Lyon-Sud Database

Gilles A. Salles, Lucile Baseggio, PharmD, PhD, Emmanuel Bachy, MD PhD, Clementine Sarkozy, MD, Herve Ghesquieres, MD PhD, Joris Diels, PhD, Hervé Besson, PhD, Finlay MacDougall, BA, Ruben Hermans, PhD MSc, Nollaig Healy, PhD, Jamie Garside, MSc, Wafae Iraqi, PharmD, PhD, Evelyne Callet-Bauchu, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2039.
https://doi.org/10.1182/blood.V128.22.2039.2039
Published: 2016
Journal Articles

Identification of Previously Unrecognized CD1d-Restricted Peripheral T Cell Lymphomas (PTCLs) in Mouse and Human Reveals Blocking Anti-CD1d Monoclonal Antibodies As a New Therapeutic Possibility in PTCLs

Emmanuel Bachy, MDPhD, Mirjam Urb, PhD, Gabriel Bricard, PhD, Shilpi Jayaswal, PhD, Remy Robinot, Alexandra Traverse-Glehen, MD PhD, Sophie Gazzo, PhD, Lucile Baseggio, PharmD PhD, Martine Ffrench, MD PhD, Paul Mondiere, Morgan Taillardet, PhD, Gilles Salles, MDPhD, Joel Lachuer, PhD, Olivier Hermine, MD PhD, Vahid Asnafi, MDPhD, Mikael Roussel, MD PhD, Thierry Lamy, Patrice Marche, PhD, Philippe Gaulard, MD, Mitchell Kronenberg, PhD, Thierry Defrance, PhD, Laurent Genestier, PhD
Journal: Blood
Blood (2014) 124 (21): 4485.
https://doi.org/10.1182/blood.V124.21.4485.4485
Published: 2014